Don Gibson Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1123 Highway 35 S, Forest, MS 39074 Phone: 601-469-4771 Fax: 601-469-4724 |
William Mark Lewis, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Ln, Forest, MS 39074 Phone: 601-469-4861 Fax: 601-469-1238 |
Rita Carol Beasley, ARNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1309 Highway 35 S, Forest, MS 39074 Phone: 601-469-9999 Fax: 601-469-9933 |
Marion Jewett Sorrels, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1080 Highway 35 S, Forest, MS 39074 Phone: 601-469-3555 Fax: 601-469-3584 |
Dr. Bernard Gayle Harrell, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1080 Highway 35 S, Forest, MS 39074 Phone: 601-469-3555 Fax: 601-469-3584 |
Austin Archie Howard Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Ln, Forest, MS 39074 Phone: 601-469-4861 Fax: 601-469-1238 |
Van-vi Le Richardson, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1080 Highway 35 S, Forest, MS 39074 Phone: 601-469-3555 Fax: 601-469-3584 |
John Paul Lee, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Ln, Forest, MS 39074 Phone: 601-469-4861 Fax: 601-469-1238 |
News Archive
BBC News on Sunday looked at Rwanda's national circumcision campaign, which began in December 2010 to help lower the incidence of HIV in the country.
Researchers have sequenced the genetic blueprint of one of the most prolific pathogen-transmitting agents on the planet - the Lyme-disease-spreading tick (Ixodes scapularis) that bites humans. The findings could lead to advances in not only disrupting the tick's capacity to spread diseases but also in eradicating the pest.
Recently the number of genes known to be associated with Alzheimer's disease has increased from four to eight, including the MS4A gene cluster on chromosome 11.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Truvada (emtricitabine and tenofovir disoproxil fumarate), in combination with safer sex practices, to reduce the risk of sexually acquired HIV-1 infection in adults at high risk.
› Verified 6 days ago